This technology is a smart contact lens for diagnosing and treating dry eye syndrome, featuring a dry eye syndrome biomarker detection sensor and a drug reservoir.
Due to a lack of effective diagnostic methods for dry eye syndrome, new diagnostic and therapeutic solutions were needed.
This technology diagnoses by detecting current changes caused by the field effect when biomarkers bind to a probe. It then simultaneously treats by controlling drug release through the electrical melting of a gold film in the drug reservoir.
US2022-0386863A1